The Asia-Pacific pharmaceutical market has expanded rapidly in the past six months, primarily driven by the strong economic growth, rising, affluent, middle-class that contributed greater demand for healthcare as well as continuous governments’ commitments in containing costs and improving healthcare access through various healthcare reforms.